Erez Israeli
Erez Israeli is the Chief Executive Officer of Dr. Reddy’s Laboratories Ltd., an Indian multinational pharmaceutical company. Under his leadership, the company has focused on expanding its generic drug portfolio, including efforts to introduce generic versions of key therapies like semaglutide in major markets. Recently, he addressed the company's plans and challenges regarding regulatory approvals for semaglutide, a popular diabetes and weight-loss medication.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Erez Israeli is the CEO of Dr. Reddy’s, which plans to launch the generic version of semaglutide in 87 countries.
7
Canada:
Erez Israeli, the drugmaker’s chief executive officer, said on an earnings call on July 23 that the company was prioritizing a launch in Canada.
6